Administration of the OGG1 inhibitor, TH5487, which displaces 8-oxoG from the active binding site of OGG1, decreased tissue remodeling and bleomycin-induced pulmonary fibrosis in murine models (27,28). The gene discussed is OGG1; the disease is pulmonary fibrosis.